Broadening the Horizons of RNA Delivery Strategies in Cancer Therapy
RNA-based therapy is a promising and innovative strategy for cancer treatment. However, poor stability, immunogenicity, low cellular uptake rate, and difficulty in endosomal escape are considered the major obstacles in the cancer therapy process, severely limiting the development of clinical transla...
Main Authors: | Shuaiying Wu, Chao Liu, Shuang Bai, Zhixiang Lu, Gang Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Bioengineering |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-5354/9/10/576 |
Similar Items
-
Human β-Defensin 23 as a Carrier for In Vitro and In Vivo Delivery of mRNA
by: Kyoung-Ran Kim, et al.
Published: (2023-10-01) -
Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
by: Liusheng Wu, et al.
Published: (2024-02-01) -
siRNA therapeutics and its challenges: Recent advances in effective delivery for cancer therapy
by: Arpita Paul, et al.
Published: (2022-07-01) -
Lipid carriers for mRNA delivery
by: Wanting Zhang, et al.
Published: (2023-10-01) -
Delivery Times and Delay in Delivery of Consignment under the Conditions of International Carriage
by: Jarmila Sosedová, et al.
Published: (2021-10-01)